Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.46 USD | -2.36% | -12.76% | +19.48% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.48% | 1.91B | |
+34.91% | 51.07B | |
-8.20% | 38.78B | |
+35.03% | 38.61B | |
-8.98% | 27.32B | |
+11.63% | 26.35B | |
-19.12% | 19.46B | |
+40.45% | 13.58B | |
+30.25% | 12.46B | |
-4.11% | 11.75B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- B. Riley Lowers Kymera Therapeutics' PT to $16 From $37 Following Disappointing Oncology Updates, Keeps Neutral Rating